Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium.
GyrA changes (at M95 or D99) occurred at a frequency of 5.0% (7/140) but could not be correlated with treatment outcome because they occurred concurrently with S83 changes in ParC.
No comments yet. Be the first to comment!
Integrating the Human and Animal Sides of Mycoplasmas Resistance to Antimicrobials.
Mutations in gyrA are associated with fluoroquinolone resistance.
JMM Profile: Mycoplasma genitalium: a small, yet significant pathogen.
Spread of dual-class drug-resistant Mycoplasma genitalium in Tokyo, Japan, 2023-2025.
High prevalence of circulating dual-class resistant Mycoplasma genitalium in asymptomatic MSM in Tokyo, Japan.
Effectiveness of sitafloxacin monotherapy for quinolone-resistant rectal and urogenital Mycoplasma genitalium infections: a prospective cohort study.
Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.
Mutations in GyrA contribute to moxifloxacin resistance.
Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitalium.
Single nucleotide polymorphisms in gyrA
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research